Literature DB >> 11950339

Synthesis and NKT cell stimulating properties of fluorophore- and biotin-appended 6"-amino-6"-deoxy-galactosylceramides.

Xiao-Ti Zhou1, Claire Forestier, Randal D Goff, Chunhong Li, Luc Teyton, Albert Bendelac, Paul B Savage.   

Abstract

Alpha-galactosylceramides are potent stimulators of human T cells. Stimulation occurs through binding of the glycolipids by CD1d, presentation to T cells, and formation of a CD1d-glycolipid-T cell receptor complex. To facilitate the elucidation of the structural features of glycolipids necessary for T cell stimulation, alpha-galactosylceramides have been prepared with small molecules appended at the C6 position of the sugar. The appended molecules do not significantly influence the abilities of the glycolipids to stimulate T cells. [reaction: see text]

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950339     DOI: 10.1021/ol025565+

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  29 in total

1.  Divergent synthetic approach to 6''-modified α-GalCer analogues.

Authors:  Nora Pauwels; Sandrine Aspeslagh; Gerd Vanhoenacker; Koen Sandra; Esther D Yu; Dirk M Zajonc; Dirk Elewaut; Bruno Linclau; Serge Van Calenbergh
Journal:  Org Biomol Chem       Date:  2011-11-01       Impact factor: 3.876

2.  Synthesis and evaluation of 3''- and 4''-deoxy and -fluoro analogs of the immunostimulatory glycolipid, KRN7000.

Authors:  Ravinder Raju; Bernard F Castillo; Stewart K Richardson; Meena Thakur; Ryan Severins; Mitchell Kronenberg; Amy R Howell
Journal:  Bioorg Med Chem Lett       Date:  2009-06-06       Impact factor: 2.823

3.  Synthesis of all stereoisomers of KRN7000, the CD1d-binding NKT cell ligand.

Authors:  Jeong-Ju Park; Ji Hyung Lee; Subhash C Ghosh; Gabriel Bricard; Manjunatha M Venkataswamy; Steven A Porcelli; Sung-Kee Chung
Journal:  Bioorg Med Chem Lett       Date:  2008-06-14       Impact factor: 2.823

4.  4"-O-Alkylated α-Galactosylceramide Analogues as iNKT-Cell Antigens: Synthetic, Biological, and Structural Studies.

Authors:  Jonas Janssens; Aruna Bitra; Jing Wang; Tine Decruy; Koen Venken; Johan van der Eycken; Dirk Elewaut; Dirk M Zajonc; Serge van Calenbergh
Journal:  ChemMedChem       Date:  2018-12-17       Impact factor: 3.466

Review 5.  Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.

Authors:  James E East; Andrew J Kennedy; Tonya J Webb
Journal:  Med Res Rev       Date:  2012-12-13       Impact factor: 12.944

6.  Novel galactosyl donor with 2-naphthylmethyl (NAP) as the non participating group at C-2 position: Efficient synthesis of alpha-galactosyl ceramide.

Authors:  Sirajud D Khaja; Vipin Kumar; Misbah Ahmad; Jun Xue; Khushi L Matta
Journal:  Tetrahedron Lett       Date:  2010-08-18       Impact factor: 2.415

7.  Amide-Linked C4″-Saccharide Modification of KRN7000 Provides Potent Stimulation of Human Invariant NKT Cells and Anti-Tumor Immunity in a Humanized Mouse Model.

Authors:  Noemi Alejandra Saavedra-Avila; Santosh Keshipeddy; Matthew J Guberman-Pfeffer; Ayax Pérez-Gallegos; Neeraj K Saini; Carolina Schäfer; Leandro J Carreño; José A Gascón; Steven A Porcelli; Amy R Howell
Journal:  ACS Chem Biol       Date:  2020-12-09       Impact factor: 5.100

8.  Synthesis of diglycosylceramides and evaluation of their iNKT cell stimulatory properties.

Authors:  Yang Liu; Shenglou Deng; Li Bai; Stefan Freigang; Jochen Mattner; Luc Teyton; Albert Bendelac; Paul B Savage
Journal:  Bioorg Med Chem Lett       Date:  2008-01-01       Impact factor: 2.823

9.  The roles of 3' and 4' hydroxy groups in alpha-galactosylceramide stimulation of invariant natural killer T cells.

Authors:  Chengfeng Xia; Wenpeng Zhang; Yalong Zhang; Wenlan Chen; Janos Nadas; Ryan Severin; Robert Woodward; Bin Wang; Xin Wang; Mitchell Kronenberg; Peng G Wang
Journal:  ChemMedChem       Date:  2009-11       Impact factor: 3.466

Review 10.  Glycolipids as immunostimulating agents.

Authors:  Douglass Wu; Masakazu Fujio; Chi-Huey Wong
Journal:  Bioorg Med Chem       Date:  2007-10-13       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.